Agios to Present Data from AG-270 Phase 1 Dose-Escalation Study in Patients with MTAP-Deleted Tumors in a Proffered Papers Oral Presentation and Poster Session at the AACR-NCI-EORTC International Conference Read more about Agios to Present Data from AG-270 Phase 1 Dose-Escalation Study in Patients with MTAP-Deleted Tumors in a Proffered Papers Oral Presentation and Poster Session at the AACR-NCI-EORTC International Conference
Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients Read more about Data from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO® Demonstrates Significant Improvement in Progression Free Survival (PFS) Compared to Placebo in Previously Treated IDH1 Mutant Cholangiocarcinoma Patients
Q3 2019 Agios Pharmaceuticals Inc Earnings Conference Call Read more about Q3 2019 Agios Pharmaceuticals Inc Earnings Conference Call
Agios to Present Data From the Phase 3 ClarIDHy Study of TIBSOVO® in Previously Treated IDH1 Mutant Cholangiocarcinoma in Presidential Symposium at ESMO Read more about Agios to Present Data From the Phase 3 ClarIDHy Study of TIBSOVO® in Previously Treated IDH1 Mutant Cholangiocarcinoma in Presidential Symposium at ESMO
Agios Announces Publication of Data for Mitapivat from Core and Extension Phases of the DRIVE PK Study in Patients with Pyruvate Kinase Deficiency in the New England Journal of Medicine Read more about Agios Announces Publication of Data for Mitapivat from Core and Extension Phases of the DRIVE PK Study in Patients with Pyruvate Kinase Deficiency in the New England Journal of Medicine
Agios to Present at the Citi 14th Annual Biotech Conference on Thursday, September 5, 2019 Read more about Agios to Present at the Citi 14th Annual Biotech Conference on Thursday, September 5, 2019
Agios at Citi 14th Annual Biotech Conference Read more about Agios at Citi 14th Annual Biotech Conference
Agios Reports Business Highlights and Second Quarter 2019 Financial Results Read more about Agios Reports Business Highlights and Second Quarter 2019 Financial Results
Agios to Webcast Conference Call of Second Quarter 2019 Financial Results on August 1, 2019 Read more about Agios to Webcast Conference Call of Second Quarter 2019 Financial Results on August 1, 2019
Q2 2019 Agios Pharmaceuticals Inc Earnings Conference Call Read more about Q2 2019 Agios Pharmaceuticals Inc Earnings Conference Call